Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/2008
12/25/2008US20080318257 Transient receptor potential cation channel for use in identifying modulators for prevention and treatment of cell proliferative and nervous system disorders; hybridoma cell line; radioimmunoassay; kits
12/25/2008US20080318254 PSCA antibodies and hybridomas producing them
12/25/2008US20080318253 Monoclonal anti-idiotypic antibody; antitumor agents; anticarcinogenic agents; antiproliferative agents; immunotherapy; hormone antagonist therapy
12/25/2008US20080318251 G protein coupled receptors for use as tools in identifying modulators of taste perception
12/25/2008US20080318229 Method for Diagnosing Neuro-Degenerative Disease
12/25/2008US20080318022 Outer layer material having entanglement of hydrophobic polymer host blended with a maleated hydrophobic polymer co-host, and hydrophilic polymer guest
12/25/2008US20080317837 Peptide fragment with immunogenic or therapeutic properties against ischemic cardiovascular diseases
12/25/2008US20080317787 Anti-Malaria Vaccine
12/25/2008US20080317783 Light chain that cleaves a neurosecretory protein; an HN domain that translocates the light chain across an endosome membrane and a substance P targeting moiety; the HC domain is removed or modified to reduce the targeting of the modified Clostridial toxin to the neuromuscular junction
12/25/2008US20080317782 Light chain that cleaves a neurosecretory protein; an HN domain that translocates the light chain across an endosome membrane and a substance P targeting moiety; the HC domain is removed or modified to reduce the targeting of the modified Clostridial toxin to the neuromuscular junction
12/25/2008US20080317775 Bacterial Antigens and Uses Thereof
12/25/2008US20080317773 Conjugates that contain the homeodomain of antennapedia
12/25/2008US20080317772 Compounds and methods for treatment and diagnosis of chlamydial infection
12/25/2008US20080317771 Anti-Clusterin Oligoclonal Antibodies for Diagnosis and Prediction of the Aggressiveness of Tumours, Diagnostic Method and Related Kits
12/25/2008US20080317766 Costimulatory Molecules and Uses Thereof
12/25/2008US20080317762 Bacterial Contact Inhibition and Methods Therefor
12/25/2008US20080317759 Therapeutic uses of factors which inhibit or neutralize MIF activity
12/25/2008US20080317756 Antibodies to Chemokine Alpha-5
12/25/2008US20080317755 Compositions and methods for the therapy and diagnosis of colon cancer
12/25/2008US20080317754 Human Osteoclast Derived Cathepsin
12/25/2008US20080317748 Using DCRS5 cytokine receptors modulators to treat psoriasis and atopic dermatitis
12/25/2008US20080317738 Mylks as Modifiers of Branching Morphogenesis and Methods of Use
12/25/2008US20080317716 Antigen, nucleic acid that encodes fusion protein; therapy, prevention of tuberculosis infections
12/25/2008US20080317713 Derivatives of growth hormone and related proteins
12/25/2008US20080317707 Pegylated interleukin-10
12/25/2008US20080317670 Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acids and Polypeptides
12/25/2008US20080317669 Cloning of honey bee allergen C
12/25/2008US20080313823 Support-Colouring Means
12/24/2008WO2008157776A2 Modified diphtheria toxins
12/24/2008WO2008157729A2 Methods for predicting three-dimensional structures for alpha helical membrane proteins and their use in design of selective ligands
12/24/2008WO2008157697A2 Copolymer assay
12/24/2008WO2008157473A1 Use of tlr agonists and/or type 1 interferons to alleviate toxicity of tnf-r agonist therapeutic regimens
12/24/2008WO2008157432A1 Polynucleotides and methods for making plants resistant to fungal pathogens
12/24/2008WO2008157419A2 Immunogenic peptides of influenza virus
12/24/2008WO2008157380A2 Chemically modified cyclic peptides containing cell adhesion recognition (car) sequences and uses therefor
12/24/2008WO2008157378A2 Rage fusion proteins
12/24/2008WO2008157370A2 Secondary wall forming genes from maize and uses thereof
12/24/2008WO2008157367A1 Fusion proteins containing two tgf-beta binding domains of tgf-beta type ii receptor
12/24/2008WO2008157350A2 Methods and materials for reducing biofilms
12/24/2008WO2008157263A2 Methods of delivery of molecules to cells using a ricin subunit and compositions relating to same
12/24/2008WO2008156681A2 Adenoviral vectors for influenza virus production
12/24/2008WO2008156655A2 Vaccinia virus vectors encoding a sodium-dependent transporter protein for imaging and/or treatment of tumors
12/24/2008WO2008156637A2 Biocompatible coated nanostructured titanium surfaces
12/24/2008WO2008156428A2 Novel peptides and protein and uses thereof
12/24/2008WO2008156363A1 Selective inhibitors of the nuclear factor of activated t-cells
12/24/2008WO2008156183A1 Hepatocellular carcinoma protein marker, and method for detection of hepatocellular carcinoma using the same
12/24/2008WO2008155918A1 REGULATION OF HIF-1 BY MT1-MMP, iFIH AND FIH-1
12/24/2008WO2008155900A1 Glp-1 peptide having sugar chain attached thereto
12/24/2008WO2008155891A1 Novel marker for arteriosclerotic disease
12/24/2008WO2008155872A1 Method of arranging ferritin and method of arranging inorganic particles
12/24/2008WO2008155509A2 Modified human factor vii/viia and pharmaceutical composition containing same
12/24/2008WO2008155363A2 Identification of new isoforms of the mhc-class i specific receptor cd160 and uses thereof
12/24/2008WO2008155316A1 Immunogenic compositions associated with sars corona virus spike protein
12/24/2008WO2008155304A1 Synthetic repetitive proteins, the production and use thereof
12/24/2008WO2008155291A2 Chlamydia antigens
12/24/2008WO2008155134A1 Biological active proteins having increased in vivo and/or vitro stability
12/24/2008WO2008155133A2 Fusion protein comprising a caspase domain and a nuclear hormone receptor binding domain and methods and uses thereof
12/24/2008WO2008155054A1 Farnesoid-x-receptor mutants, and crystallisation thereof
12/24/2008WO2008154868A1 Capsid proteins and uses therefore
12/24/2008WO2008154867A1 Material with immunogenicity
12/24/2008WO2008154814A1 OPTIMIZED TACI-Fc FUSION PROTEINS
12/24/2008WO2008154813A1 Monoclonal antibodies binding to avian influenza virus subtype h5 haemagglutinin and uses thereof
12/24/2008WO2008154738A1 Azapeptides as cd36 binding compounds
12/24/2008WO2008154719A1 Recombinant human interferon-like proteins
12/24/2008WO2008154700A1 Compositions and uses thereof for the treatment of acute respiratory distress syndrome (ards) and clinical disorders associated with therewith
12/24/2008WO2008138001A3 Synthetic peptides and peptide mimetics
12/24/2008WO2008133929A3 Cell permeable miniature proteins
12/24/2008WO2008131293A3 Oriented collagen-based materials, films and methods of making same
12/24/2008WO2008124086A3 Chimeric activators: quantitatively designed protein therapeutics and uses thereof
12/24/2008WO2008119358A3 Surface-located streptococcus pneumoniae polypeptides for use in vaccine compositions
12/24/2008WO2008118386A3 Method for detecting autoprocessed, secreted pcsk9
12/24/2008WO2008115390A3 Methods of using defensins to treat diabetes
12/24/2008WO2008115303A3 Potent and selective mediators of cholesterol efflux
12/24/2008WO2008113970A3 Peptides
12/24/2008WO2008112840A3 Novel composition and methods for the treatment of immune related diseases
12/24/2008WO2008109757A3 Methods and compositions involving polymeric immunoglobulin fusion proteins
12/24/2008WO2008100470A3 Rage - immunoglobulin fusion proteins
12/24/2008WO2008091306B1 Methods to utilize invertebrate chemosensory proteins for industrial and commercial uses
12/24/2008WO2008089234A3 Natural polypeptides for oral health care
12/24/2008WO2008085543A3 Multimeric elp fusion constructs
12/24/2008WO2008076487A3 Antibodies and methods for making and using them
12/24/2008WO2008073615A9 N-glycosylation mutant of melanoma differentiation associated gene-7
12/24/2008WO2008067279A3 Biological pacemakers including mutated hyperpolarization-activated cyclic nucleotide-gated (hcn) channels
12/24/2008WO2008033374A3 Ocl-2a3 compositions and uses thereof
12/24/2008WO2008028068A3 NON-HUMAN PRIMATE FCεR1α POLYPEPTIDES
12/24/2008WO2008024105A3 Nanocomposites of repeat sequence proteins and phyllosilicate clays and their preparation
12/24/2008WO2008021088A3 Salicylanilides enhance oral delivery of therapeutic peptides
12/24/2008WO2008019368A3 Albumin-insulin fusion proteins
12/24/2008WO2008014521A3 Improved vaccines and methods for using the same
12/24/2008WO2008008709A3 Method of selective protein enrichment and associated applications
12/24/2008WO2007132193A8 Modified vird2 protein and its use in improved gene transfer
12/24/2008WO2007109360A3 Tem8 as an adjuvant and uses thereof
12/24/2008WO2006088597A3 A plasmodium vivax hybrid circumsporozoite protein and vaccine
12/24/2008EP2006384A1 Preprocalcitonin-derived antigen epitopes
12/24/2008EP2006382A1 Dopamine-producing neuron progenitor cell marker 187a5
12/24/2008EP2006376A1 Fusion protein comprising a caspase domain and a nuclear hormone receptor binding domain and methods and uses thereof
12/24/2008EP2006303A1 Recombinant antibodies specific for Beta-Amyloid ends, DNA encoding and methods of use thereof
12/24/2008EP2006302A2 Protein complex and process for production thereof
12/24/2008EP2006301A1 Peptide-based immunization therapy for treatment of atherosclerosis
12/24/2008EP2006300A2 Characterization of a calcium channel family